Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteleerink.com
Twitter@Leerink
Phone617-248-1601
Emailwebrequest@leerin...
Employees
Founded1995

Funds

Offices

People

Managing Director, Head of Institutional Sales
Managing Director, Head of Institutional Trading
Managing Director, Head of Equity Research
President & CEO
Vice Chairman
Board of Managers
Board of Managers
Board of Managers
Show All People

Tags

Leerink Swann

Leerink Swann combines financial expertise and healthcare insight to enable clients to make the best-informed investment decisions. They use knowledge and abilities to advise clients on their healthcare investments, enhancing their fortunes and helping pave the way for future medical breakthroughs.

Single-Industry Focus The quality of understanding and perspectives is generated by single-industry focus in healthcare. As a result, clients who require success in the healthcare industry rely on Leerink Swann.

Exclusive Insights The insights come from two groups of specialists: investment professionals and more than 35,000-member MEDACorp network. The investment professionals apply their deep financial experience exclusively to the healthcare sector. MEDACorp delivers real-world answers about current and future developments on a wide range of healthcare topics. No other investment bank can boast the depth of expertise or ease of direct communication with network members that we can. The acumen and individualized attention make the value of knowledge unequalled.

Exceptional Decision Support By uniting the industry intelligence of investment bankers and strategic advisory team with the expert insight of MEDACorp, Leerink Swann offers compelling solutions and services available to investment managers and healthcare companies, allowing clients to be confident in their investment decisions.

Ideally Suited for Emerging Growth Leerink Swann’s unique business model makes us an outstanding partner to serve emerging-growth healthcare companies, as well as larger companies seeking to learn about the emerging growth space. They believe unique knowledge resources help companies devise and execute superior growth strategies. By activating domain expertise, Leerink Swann can optimize company positioning, identify and educate investors and uncover value-enhancing assets or merger partners - all with the goal of enhancing clients’ outcomes.

Recent Milestones

Investments

Company Date Round Size Participants
Living Proof 2/2013Series C$30M2
Humedica 10/2009Series A$30M4

Videos

Sources

  1. Living Proof, Shampoo Maker Staffed by Doctors, Raises $30M Series C (pevc.dowjones.com) [edit]
  2. Humedica, Inc.: Series A $30M (onbiovc.com) [edit]
Edit This Page
Last Edited 3/29/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy